Literature DB >> 24625330

Fibrin sealants: surgical hemostat, sealant and adhesive.

Samuel P Mandell1, Nicole S Gibran.   

Abstract

INTRODUCTION: Fibrin sealants (FS) have been approved for use in the United States since 1998. Since approval, they have been used in a wide variety of clinical settings and new products continue to be introduced. AREAS COVERED: This review covers the literature supporting the USA FDA-approved indications for FS products produced by Baxter Corp. Literature review of PubMed, the Cochrane Library, FDA approval documents and product websites yielded information contained in this article. Mechanism of action, efficacy and safety of these products are covered. EXPERT OPINION: FS are generally safe, popular and are used for a wide variety of off-label indications. Their use appears to be expanding rapidly. For many uses, including approved ones, large well-controlled trials are still needed. Additionally, cost-effectiveness data for these products would be a great benefit in guiding their future use.

Keywords:  adhesive; fibrin sealant; fibrinogen; hemostasis; sealant; skin graft; surgery; thrombin

Mesh:

Substances:

Year:  2014        PMID: 24625330     DOI: 10.1517/14712598.2014.897323

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  11 in total

1.  Percutaneous perirenal thrombin injection for the treatment of acute hemorrhage after renal biopsy.

Authors:  Sebastian Mafeld; Michael McNeill; Philip Haslam
Journal:  Diagn Interv Radiol       Date:  2016 Mar-Apr       Impact factor: 2.630

Review 2.  Application and outlook of topical hemostatic materials: a narrative review.

Authors:  Yuting Zhong; Huayu Hu; Ningning Min; Yufan Wei; Xiangdong Li; Xiru Li
Journal:  Ann Transl Med       Date:  2021-04

3.  High-level expression and preparation of recombinant human fibrinogen as biopharmaceuticals.

Authors:  Masaki Hirashima; Takayuki Imamura; Kentaro Yano; Ryoichi Kawamura; Akihiro Meta; Yoshiyuki Tokieda; Toshihiro Nakashima
Journal:  J Biochem       Date:  2015-10-15       Impact factor: 3.387

Review 4.  Elastic sealants for surgical applications.

Authors:  Nasim Annabi; Kan Yue; Ali Tamayol; Ali Khademhosseini
Journal:  Eur J Pharm Biopharm       Date:  2015-06-12       Impact factor: 5.571

Review 5.  Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding.

Authors:  DaShawn A Hickman; Christa L Pawlowski; Ujjal D S Sekhon; Joyann Marks; Anirban Sen Gupta
Journal:  Adv Mater       Date:  2017-11-22       Impact factor: 30.849

6.  Pressure-Sensitive Tissue Adhesion and Biodegradation of Viscoelastic Polymer Blends.

Authors:  John L Daristotle; Shadden T Zaki; Lung W Lau; Omar B Ayyub; Massi Djouini; Priya Srinivasan; Metecan Erdi; Anthony D Sandler; Peter Kofinas
Journal:  ACS Appl Mater Interfaces       Date:  2020-03-25       Impact factor: 9.229

7.  Facile Preparation of Tunicate-Inspired Chitosan Hydrogel Adhesive with Self-Healing and Antibacterial Properties.

Authors:  Xiang He; Ruyue Liu; Huiqing Liu; Ruixiao Wang; Zhenhao Xi; Yixiang Lin; Jie Wang
Journal:  Polymers (Basel)       Date:  2021-12-10       Impact factor: 4.329

8.  Local and systemic effects of fibrin and cyanoacrylate adhesives on lung lesions in rabbits.

Authors:  Marcus V H Carvalho; Evaldo Marchi; Andre J Fruchi; Bruno V B Dias; Clovis L Pinto; Geovane R Dos Santos; Milena M P Acencio
Journal:  Clinics (Sao Paulo)       Date:  2017-10       Impact factor: 2.365

9.  Adipose-derived Stem/Stromal Cells on Electrospun Fibrin Microfiber Bundles Enable Moderate Muscle Reconstruction in a Volumetric Muscle Loss Model.

Authors:  Jordana Gilbert-Honick; Brian Ginn; Yuanfan Zhang; Sara Salehi; Kathryn R Wagner; Hai-Quan Mao; Warren L Grayson
Journal:  Cell Transplant       Date:  2018-10-09       Impact factor: 4.064

10.  Ex vivo evaluation of a multilayered sealant patch for watertight dural closure: cranial and spinal models.

Authors:  A Kinaci; S van Thoor; S Redegeld; M Tooren; T P C van Doormaal
Journal:  J Mater Sci Mater Med       Date:  2021-07-23       Impact factor: 4.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.